Children with type 1 diabetes have been able to use pioneering artificial pancreas technology, developed at the University of Cambridge, for the first time overnight at home without the supervision of researchers.

A ‘trouble maker’ from a bygone method of glass production could find a new use as an optical diffuser in medical laser treatments, communications systems and household lighting.

A newly-developed coating could enable buildings to have antireflective self-cleaning windows and could increase the efficiency of solar cells.

The biggest-ever return to the University seed funds was the highlight of another successful year for the University’s commercialisation arm.

A new technique for determining what causes stem cells to convert into other cell types could revolutionise our understanding of how genes function.

Researchers have identified how the ‘wall’ around cancer tumours functions and how to break it down, enabling the body’s own defences to reach and kill the cancer cells within.

New sequencing technology is transforming epigenetics research, and could greatly improve understanding of cancer, embryo formation, stem cells and brain function.

A new £50 million investment business has been launched to support the development of University spin-outs and other early-stage technology companies in the Cambridge Cluster.

Instead of harming the economies of developing countries, carbon offsets and taxes on shipping and aviation would have a minimal or even a positive economic impact if implemented wisely, according to a new study.

A new, highly-accurate temperature sensor could save manufacturers millions in maintenance costs, lower fuel consumption, and prolong the lifespan of jet engines, nuclear reactors and other types of large gas turbine engines.